- Home
- SNSE vs HYFM Comparison
SNSE vs HYFM Comparison
Compare SNSE & HYFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNSE
- HYFM
- Stock Information
- Founded
- SNSE 2005
- HYFM 1977
- Country
- SNSE United States
- HYFM United States
- Employees
- SNSE N/A
- HYFM N/A
- Industry
- SNSE Biotechnology: Pharmaceutical Preparations
- HYFM Industrial Machinery/Components
- Sector
- SNSE Health Care
- HYFM Industrials
- Exchange
- SNSE Nasdaq
- HYFM Nasdaq
- Market Cap
- SNSE 14.5M
- HYFM 15.0M
- IPO Year
- SNSE 2021
- HYFM 2020
- Fundamental
- Price
- SNSE $11.71
- HYFM $2.77
- Analyst Decision
- SNSE Strong Buy
- HYFM
- Analyst Count
- SNSE 4
- HYFM 0
- Target Price
- SNSE $72.50
- HYFM N/A
- AVG Volume (30 Days)
- SNSE 56.5K
- HYFM 35.3K
- Earning Date
- SNSE 11-13-2025
- HYFM 11-06-2025
- Dividend Yield
- SNSE N/A
- HYFM N/A
- EPS Growth
- SNSE N/A
- HYFM N/A
- EPS
- SNSE N/A
- HYFM N/A
- Revenue
- SNSE N/A
- HYFM $161,102,000.00
- Revenue This Year
- SNSE N/A
- HYFM N/A
- Revenue Next Year
- SNSE N/A
- HYFM $37.86
- P/E Ratio
- SNSE N/A
- HYFM N/A
- Revenue Growth
- SNSE N/A
- HYFM N/A
- 52 Week Low
- SNSE $5.00
- HYFM $1.50
- 52 Week High
- SNSE $18.35
- HYFM $8.55
- Technical
- Relative Strength Index (RSI)
- SNSE 53.46
- HYFM 36.29
- Support Level
- SNSE $11.00
- HYFM $2.62
- Resistance Level
- SNSE $18.35
- HYFM $3.42
- Average True Range (ATR)
- SNSE 1.55
- HYFM 0.25
- MACD
- SNSE 0.36
- HYFM 0.00
- Stochastic Oscillator
- SNSE 27.83
- HYFM 17.44
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).
About HYFM Hydrofarm Holdings Group Inc.
Hydrofarm Holdings Group Inc is a distributor and manufacturer of agriculture equipment and supplies. Some of its products includes lighting solutions, growing media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies sold under proprietary, exclusive/preferred brands, or non-exclusive/distributed brands. The business is organized into two operating segments, the U.S. and Canada.